Concepedia

Jonathan E. Knikman

JE

Statistics

Publications

3

Citations

122

H-Index

3

Active since

2022

Affiliations

Deventer Ziekenhuis(Current)

Erasmus MC Cancer Institute

The Netherlands Cancer Institute

Utrecht University

Oncode Institute

Jonathan E. Knikman is an author at Deventer Ziekenhuis specializing in pharmacogenomics, medicine, and pharmacology.

Publications per year

2022–2024

3

Publications

3

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study

Mirjam de With, Jonathan E. Knikman, Femke M. de Man et al. · Clinical Pharmacology & Therapeutics · 2022 · 56 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +14

Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis

Jonathan E. Knikman, Tycho A. Wilting, Marta López‐Yurda et al. · Journal of Clinical Oncology · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD

Jonathan E. Knikman, Qinglian Zhai, Carin A.T.C. Lunenburg et al. · Genome Medicine · 2024 · 11 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

1–3 of 3